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BACKGROUND AS PROVIDED BY THE EUROPEAN COMMISSION
The European Community legislation lists nutritional substances that may be used for nutritional purposes in certain categories of foods as sources of certain nutrients.
The Commission has received a request for the evaluation of biotin-enriched yeast added for nutritional purposes to food supplements. The relevant Community legislative measure is:
• Directive 2002/46/EC of the European Parliament and of the Council on the approximation of the laws of the Member States relating to food supplements.
TERMS OF REFERENCE AS PROVIDED BY THE EUROPEAN COMMISSION
In accordance with Article 29 (1) (a) of Regulation (EC) No 178/2002, the European Commission asks the European Food Safety Authority to provide a scientific opinion, based on its consideration of the safety and bioavailability of biotin-enriched yeast added for nutritional purposes to food supplements.
STATEMENT

Introduction
Following a request from the European Commission to the European Food Safety Authority (EFSA), the Scientific Panel on Food Additives and Nutrient Sources added to Food (ANS) was asked to provide a scientific opinion on the safety of biotin-enriched yeast added for nutritional purposes as a source of biotin in food supplements and on the bioavailability of biotin from this source.
Summary of the information provided in the supporting dossier on biotin-enriched yeast
Biotin-enriched yeast is derived from cultures of specified strains of Saccharomyces cerevisiae grown in the presence of biotin. Fermentation takes place at a specified temperature and pressure for defined periods of time. This is followed by increasing the temperature to kill the yeast. The cell wall is ruptured enzymatically to release the contents which are then spray dried.
The petitioner has provided some general information on the manufacturing process, but no details on the procedures used to produce biotin-enriched yeast are provided.
According to the petitioner, biotin in biotin-enriched yeast is naturally integrated by the growing yeast into its own structure and occurs therefore, in the way biotin would be present in any food material.
The petitioner states that during fermentation in the presence of biotin, a specific strain of Saccharomyces cerevisiae incorporates biotin into 'biological complexes', the metabolic fate and the biological distribution of which are similar to those of other sources of biotin in the diet.
The petitioner states that "the integration will be chemically multi-formatted by the organism and therefore, its chemical name, formula, chemical family and CAS Registry Number is undefined". Further details on the chemical characterisation of the fermentation products to demonstrate that the expected complexes of the biotin are present in the enriched yeast were not provided.
Comparative Fourier Transform Infrared (FTIR) spectra of the starter yeast, biotin, biotinenriched yeast and a simple mixture of yeast and biotin have been provided.
Biotin-enriched yeast is described as an amorphous hygroscopic powder, soluble in water at 20°C.
According to the petitioner, biotin is present at 0.5% of the source. The remaining 99.5% is made up of enzymatically ruptured yeast cells.
The petitioner also provides microbiological specifications. Specifications for lead, mercury, cadmium and arsenic were not provided.
Specific proposals for use levels for biotin-enriched yeast were not provided. The petitioner only states that biotin-enriched yeast is currently used to provide between 50 µg biotin/day up to a maximum of 300 µg biotin/day, depending on the type of supplement. 
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